The ethics of radiation exposure in cancer-treated patients

The ethics of radiation exposure in cancer-treated patients EDITORIAL The ethics of radiation exposure in cancer- treated patients Editorial for: Frequent MUGA testing in a myeloma patient: a case-based ethics discussion a a,b Carol Chen-Scarabelli, PhD, and Tiziano M. Scarabelli, MD, PhD Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL Received May 23, 2016; accepted May 23, 2016 doi:10.1007/s12350-016-0567-3 patients treated with doxorubicin initially surfaced in the See related article, pp. 1350–1354 1970s. Its broad availability, few technical limitations, the accuracy and reproducibility of the measurements of left ventricular function, and the development of a standardized technique for monitoring anthracycline- Cardiovascular disease is the leading cause of induced cardiac dysfunction led the MUGA scan to mortality worldwide, accounting for more than 17.3 become the preferred imaging modality in the 1980s for million deaths per year. In the USA, cardiovascular monitoring of doxorubicin-associated cardiotoxicity, disease is the most common cause of death, followed by with serial MUGA assessments commonly performed cancer, which accounts for nearly 1 of every 4 deaths. for ongoing, interval surveillance of left ventricular Cancer treatments may include potentially cardiotoxic 6,7 function. However, the later awareness of radiation agents, whose http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Nuclear Cardiology Springer Journals

The ethics of radiation exposure in cancer-treated patients

Loading next page...
 
/lp/springer_journal/the-ethics-of-radiation-exposure-in-cancer-treated-patients-94EmuUy0fL
Publisher
Springer US
Copyright
Copyright © 2016 by American Society of Nuclear Cardiology
Subject
Medicine & Public Health; Cardiology; Nuclear Medicine; Imaging / Radiology
ISSN
1071-3581
eISSN
1532-6551
D.O.I.
10.1007/s12350-016-0567-3
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL The ethics of radiation exposure in cancer- treated patients Editorial for: Frequent MUGA testing in a myeloma patient: a case-based ethics discussion a a,b Carol Chen-Scarabelli, PhD, and Tiziano M. Scarabelli, MD, PhD Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL Received May 23, 2016; accepted May 23, 2016 doi:10.1007/s12350-016-0567-3 patients treated with doxorubicin initially surfaced in the See related article, pp. 1350–1354 1970s. Its broad availability, few technical limitations, the accuracy and reproducibility of the measurements of left ventricular function, and the development of a standardized technique for monitoring anthracycline- Cardiovascular disease is the leading cause of induced cardiac dysfunction led the MUGA scan to mortality worldwide, accounting for more than 17.3 become the preferred imaging modality in the 1980s for million deaths per year. In the USA, cardiovascular monitoring of doxorubicin-associated cardiotoxicity, disease is the most common cause of death, followed by with serial MUGA assessments commonly performed cancer, which accounts for nearly 1 of every 4 deaths. for ongoing, interval surveillance of left ventricular Cancer treatments may include potentially cardiotoxic 6,7 function. However, the later awareness of radiation agents, whose

Journal

Journal of Nuclear CardiologySpringer Journals

Published: Jun 16, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off